Intelligent Ultrasound Regulatory News (IUG)

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Capital return update

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound simulation and education company, announces that the Company has completed all the necessary administrative steps (including court approval) for the reduction of capital. This is now subject to registration at Companies House before it becomes effective after which the Company will issue a further announcement confirming registration. Once effective, the Group will have the distributable reserves required to make a material return of capital to shareholders.

The Group therefore expects to confirm the plans for its Simulation Business and the exact amount of money to be returned during December 2024.

In an update on the current year's trading the Group confirms that, as at 22 November, Group unaudited revenue was £8.1m (same period in 2023: £9.2m), with £7.4m (same period in 2023: £8.4m) from continuing operations and £0.7m (same period in 2023: £0.8m) from discontinued operations. Cash at bank was £39.6m.

For further information, please contact:

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading ultrasound simulation and education companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market. The company's main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator, the new BabyWorks Neonate and Paediatric training simulator and NeedleTrainer, which teaches real-time ultrasound-guided needling. To date over 1,800 simulators have been sold to over 800 medical institutions around the world.

www.intelligentultrasound.com